Crown Bioscience will build a second China-located CRO facility; this one will be in Taicang City, Jiangsu Province. Crown Bioscience, whose pre-clinical expertise focuses on oncology, is based in Silicon Valley. Its existing operations are located in Beijing and Indianapolis, Indiana. Taicang City is seeking to build a presence in the CRO space. Away from the major centers of Shanghai and Beijing, Taicang has not experienced the same inflation in wages as China’s major biopharma centers. More details...